Michigan Medicine 19th Annual Advanced Liver Disease and Liver Transplantation Update 2025

• Target Audience: hepatologists, gastroenterologists, transplant surgeons, internists
• Sample video: contact me for sample video
• Information:

Target Audience

Specialties – Family Medicine, Gastroenterology, General Medicine, Hepatology, Internal Medicine, Primary Care, Surgery, Transplant Surgery

Professions – House Officer, Nurse, Nurse Practitioner, Other Healthcare Professional, Physician, Physician Assistant, Social Worker

Overview

Join this hybrid program in person or virtually. This course will provide an update on recent developments in the management of patients with advanced liver disease including recent improvements in the medical management of steatotic liver disease, alcohol use disorder and alcoholic liver disease, and hepatic complications of heart disease. In addition, updates on acute on chronic liver failure, evaluation of substance use disorders in patients with advanced liver disease, liver transplantation for patients with metastatic colorectal cancer and neuroendocrine tumors, use of marginal organs in liver transplantation, and the medical management of long-term liver transplant recipients will be provided.

Objectives

At the conclusion of this activity, learners will be able to:

implement newer approaches to the diagnosis, staging, and treatment of patients with metabolic associated liver disease

use appropriate diagnostic tools and treatment strategies for patients with alcoholic liver disease

understand and recognize common hepatic manifestations of patients with congenital and acquired heart disease

understand current classification schemes and medical recommendations for patients with acute on chronic liver failure

implement how to evaluate and treat patients with substance use disorders with underlying liver disease

understand new data on the indications and outcomes with liver transplantation for patients with metastatic colorectal cancer and neuroendocrine tumors to the liver

understand what is considered a “marginal organ” for liver transplantation and how they fare in adult recipients

implement medications and treatments that are recommended for LT recipients with hyperlipidemia, cancer and metabolic bone disease

• Topics:

Agenda.pdf

Acute on Chronic Liver Failure.mp4

Detection and Management of ALD in the Outpatient Setting.mp4

Interactive Case 1 A Transplant Candidate with AUD.mp4

Management of Hyperlipidemia, Cancer, and Osteoporosis Post Liver Transplant.mp4

Medical Treatments for Steatotic Liver Disease.mp4

Panel Questions & Answers 1.mp4

Panel Questions & Answers 2.mp4

Panel Questions & Answers 3.mp4

Substance Use Disorders in Advanced Liver Disease Patients.mp4

The Heart – Liver Connection.mp4

Transplantation for Metastatic Colorectal Cancer and Neuroendocrine Tumors.mp4

Use of Marginal Organs in Liver Transplantation.mp4